SPATA2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, SPATA2 mutation is significantly associated with the RNA expression of many other genes, with 3,704 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SPATA2-associated genes across cancer lineages are MTND4P33, RNU5E-8P, and MTATP6P14. Each is linked with SPATA2 in more than 1 cancer types. Because this analysis shows association rather than direction, both SPATA2-to-partner and partner-to-SPATA2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, MTND4P33 grouped by SPATA2-low versus SPATA2-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SPATA2→partner) and Y-score (partner→SPATA2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCAMTND4P33 →+0.047+4.899<.001.00532
SKCMRNU5E-8P →+0.544+3.086<.001.00132
COADMTATP6P14 →+0.401+4.821<.001.00332
COADRN7SL607P →+0.262+3.797.007.00332
SKCMRPS20P20 →+0.073+3.132.003.00332
LUSCRN7SL135P →+0.082+4.578.001.00532
Each partner links to its Q-omics profile. Showing the 6 strongest of 3,704 associations by consensus.

MTND4P33 by SPATA2 expression — BLCA

Box plot of MTND4P33 in SPATA2-low vs SPATA2-high samples in BLCA.

Explore this box plot interactively →

Exploration